Prosensa Holding (RNA) IPO Opens Sharply Higher – StreetInsider.com (subscription)
By Dr. Matthew Watson
Prosensa Holding (RNA) IPO Opens Sharply Higher StreetInsider.com (subscription) Prosensa Holding is an innovative biotechnology company engaged in the discovery and development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company's primary focus is on rare ... Prosensa leaps in 1st day of Nasdaq tradingThe Idaho Statesman |
Uncategorized
Comments Off on Prosensa Holding (RNA) IPO Opens Sharply Higher – StreetInsider.com (subscription) |
June 30th, 2013
This author published 6012 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research